Research & Development



  雲瑯搖頭道︰“這是阿嬌的賠償!”   接連走了將近三十里的山路,雲瑯終于感到疲倦了,習慣性的鑽進左邊的一個山洞里,取出以前早就準備好的柴火,點燃之後,就與甦稚對坐在火堆兩側,相對無言。人人超碰xxoo免费视频 偷拍久久国产视频   雲瑯冷冷的看了隋越的背影一眼,低聲道︰“果真是漏洞百出啊……”   更何況,關中的叛亂是關中百姓自己平定的……這就讓皇帝的威嚴感快要降到了地上。曰本高清一本道无码av   狄山枯瘦的身軀躺在他的懷里,不論劉據如何呼喚,也不再醒來。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo